Global Hydroxychloroquine Drugs Market - Forecasts from 2025 to 2030

The global hydroxychloroquine drugs market is projected to grow at a CAGR of 2.62%, from US$1.174 billion in 2025 to US$1.336 billion in 2030.

Hydroxychloroquine is an antimalarial medication commonly used to treat malaria, as well as autoimmune diseases such as rheumatoid arthritis and lupus. It works by inhibiting inflammation and regulating the immune system, which helps reduce flare-ups of autoimmune disorders and suppresses the growth of the malaria parasite. Overall, hydroxychloroquine has a favorable side effect profile; however, it can occasionally cause gastrointestinal irritation and skin rashes, with chronic use potentially leading to retinal damage. The drug gained significant attention during the COVID-19 pandemic, although its effectiveness for this purpose has only been supported by a few limited clinical trials. While it remains a valuable option for managing various chronic conditions, careful monitoring is essential due to possible adverse effects associated with long-term use.

Drivers of the Global Hydroxychloroquine Market:

• Increasing Prevalence of Chronic Conditions: The demand for hydroxychloroquine is being driven by the rising incidence of chronic conditions such as rheumatoid arthritis, lupus, and malaria. The World Health Organization (WHO) identifies over 150 rheumatic or musculoskeletal diseases that can cause varying levels of pain and disability. Rheumatoid arthritis affects approximately 0.1% to 0.3% of the population, predominantly women in developed countries, typically between the ages of 20 and 40.

Malaria remains one of the most widespread diseases globally, treated effectively with hydroxychloroquine. According to the World Malaria Report 2024, there were an estimated 263 million cases of malaria worldwide in 2023, marking an increase from previous years. In that same year, approximately 597,000 deaths were attributed to malaria.

Geographical Insights:

The global hydroxychloroquine market is segmented into five regions: North America, South America, Europe, the Middle East & Africa, and Asia-Pacific.

• North America: The hydroxychloroquine market in North America is primarily driven by a high prevalence of autoimmune diseases such as rheumatoid arthritis and lupus that require long-term management with this medication. Increased awareness and improved diagnostic capabilities further enhance demand. The advanced healthcare infrastructure ensures easy access to hydroxychloroquine, while ongoing research explores new applications for the drug.
• Asia-Pacific: In this region, demand for hydroxychloroquine is largely influenced by a high burden of malaria, particularly in countries like India, Indonesia, and the Philippines where it plays a crucial role in malaria prevention and treatment strategies.

In summary, the global hydroxychloroquine market is expected to grow due to rising rates of chronic diseases and malaria, alongside increased awareness and advancements in healthcare infrastructure across various regions.

Reasons for buying this report:-

• Insightful Analysis: Gain detailed market insights covering major as well as emerging geographical regions, focusing on customer segments, government policies and socio-economic factors, consumer preferences, industry verticals, other sub- segments.
• Competitive Landscape: Understand the strategic maneuvers employed by key players globally to understand possible market penetration with the correct strategy.
• Market Drivers & Future Trends: Explore the dynamic factors and pivotal market trends and how they will shape up future market developments.
• Actionable Recommendations: Utilize the insights to exercise strategic decision to uncover new business streams and revenues in a dynamic environment.
• Caters to a Wide Audience: Beneficial and cost-effective for startups, research institutions, consultants, SMEs, and large enterprises.

What do businesses use our reports for?

Industry and Market Insights, Opportunity Assessment, Product Demand Forecasting, Market Entry Strategy, Geographical Expansion, Capital Investment Decisions, Regulatory Framework & Implications, New Product Development, Competitive Intelligence

Report Coverage:

• Historical data & forecasts from 2022 to 2030
• Growth Opportunities, Challenges, Supply Chain Outlook, Regulatory Framework, Customer Behaviour, and Trend Analysis
• Competitive Positioning, Strategies, and Market Share Analysis
• Revenue Growth and Forecast Assessment of segments and regions including countries
• Company Profiling (Strategies, Products, Financial Information, and Key Developments among others)

The global Hydroxychloroquine drugs market is segmented and analyzed as follows:

By Application

• Rheumatoid Arthritis
• Malaria
• Others

By End-User

• Hospitals and Clinics
• Ambulatory Surgical Centres
• Research Labs

By Geography

• North America
• USA
• Canada
• Mexico
• South America
• Brazil
• Argentina
• Rest of South America
• Europe
• United Kingdom
• Germany
• France
• Italy
• Spain
• Rest of Europe
• Middle East and Africa
• Saudi Arabia
• UAE
• Rest of the Middle East and Africa
• Asia Pacific
• China
• India
• Japan
• South Korea
• Taiwan
• Thailand
• Indonesia
• Rest of Asia-Pacific